| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 8.756 | 3.385 | 3.319 | 3.256 | 3.184 | 3.194 | 3.184 | 3.166 |
| Total Income - EUR | - | - | 8.756 | 3.385 | 3.319 | 3.256 | 3.184 | 3.194 | 3.184 | 27.974 |
| Total Expenses - EUR | - | - | 4.134 | 1.937 | 2.130 | 1.313 | 1.272 | 1.501 | 1.242 | 24.339 |
| Gross Profit/Loss - EUR | - | - | 4.622 | 1.448 | 1.189 | 1.943 | 1.912 | 1.693 | 1.942 | 3.635 |
| Net Profit/Loss - EUR | - | - | 4.534 | 1.346 | 1.089 | 1.845 | 1.823 | 1.604 | 1.647 | 3.121 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bionucex Prod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 101.232 | 99.375 | 97.450 | 95.603 | 93.483 | 93.773 | 93.488 | 97.203 |
| Current Assets | - | - | -4 | 3.388 | 2.405 | 4.345 | 5.927 | 7.550 | 9.399 | 8.202 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 3.385 | 2.371 | 4.290 | 5.905 | 7.523 | 9.370 | 8.184 |
| Cash | - | - | -4 | 3 | 34 | 55 | 22 | 27 | 29 | 18 |
| Shareholders Funds | - | - | 101.098 | 100.588 | 99.729 | 99.684 | 99.296 | 101.208 | 102.548 | 105.117 |
| Social Capital | - | - | 96.563 | 94.791 | 92.955 | 91.193 | 89.171 | 89.447 | 89.176 | 88.678 |
| Debts | - | - | 131 | 2.174 | 125 | 264 | 113 | 115 | 339 | 288 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Bionucex Prod Srl